Precision BioSciences Inc (DTIL)
9.72
-0.10
(-1.02%)
USD |
NASDAQ |
Apr 25, 16:00
9.85
+0.13
(+1.34%)
After-Hours: 20:00
Precision BioSciences Cash from Investing (TTM): 5.829M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.829M |
| September 30, 2023 | 5.155M |
| June 30, 2023 | -3.499M |
| March 31, 2023 | -3.222M |
| December 31, 2022 | -3.319M |
| September 30, 2022 | -4.192M |
| June 30, 2022 | -4.585M |
| March 31, 2022 | -5.496M |
| December 31, 2021 | -5.803M |
| September 30, 2021 | -5.394M |
| June 30, 2021 | -4.958M |
| Date | Value |
|---|---|
| March 31, 2021 | -5.053M |
| December 31, 2020 | -5.031M |
| September 30, 2020 | -9.464M |
| June 30, 2020 | -14.34M |
| March 31, 2020 | -20.69M |
| December 31, 2019 | -24.67M |
| September 30, 2019 | -29.01M |
| June 30, 2019 | -27.14M |
| March 31, 2019 | -20.13M |
| December 31, 2018 | -15.66M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-29.01M
Minimum
Sep 2019
5.829M
Maximum
Dec 2023
-8.677M
Average
-5.053M
Median
Mar 2021
Cash from Investing (TTM) Benchmarks
| Altimmune Inc | 13.73M |
| BioVie Inc | 0.2239M |
| Adial Pharmaceuticals Inc | -- |
| Gritstone Bio Inc | 102.34M |
| Humacyte Inc | -0.173M |